| For: | Chen XY, Tong GD, Xia F. Antiviral effect of Chinese medicine jiaweisinisan in hepatitis B virus transgenic mice. World J Gastroenterol 2006; 12(14): 2280-2283 [PMID: 16610037 DOI: 10.3748/wjg.v12.i14.2280] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i14/2280.htm |
| Number | Citing Articles |
| 1 |
Caixia Jia, Hongxing Wu, Aiqing Yang, Aiping Chen, Xueting Wang, Shuqin Ding, Baofeng Fan, Gangqiao Zhou, Zhihong Li, Jianxin Chen. Mechanism Research of QingReJieDu Formula for Treating Hepatitis B Virus Based on Network Pharmacology. Phytomedicine 2024; 135 doi: 10.1016/j.phymed.2024.155915
|
| 2 |
Shihao Zheng, Qiuyue Wang, Wenying Qi, Jinchi Xie, Xiaobin Zao, Xiaoke Li, Peng Zhang, Yongan Ye. The Role of Chinese Medicine in the Treatment of Chronic Hepatitis B. The American Journal of Chinese Medicine 2025; 53(05) doi: 10.1142/S0192415X25500508
|
| 3 |
Fan Zhang, Haojia Wu, Jing Wu, Kun Zhou. Network pharmacology and molecular docking reveal the active compounds and key targets of JiaWei SiNi San in hepatocellular carcinoma. Current Pharmaceutical Analysis 2026; 22(8) doi: 10.1016/j.cpan.2026.09.006
|